SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-14-050940
Filing Date
2014-02-13
Accepted
2014-02-13 15:43:52
Documents
2
Group Members
ABERDARE GP III, L.L.C.ABERDARE PARTNERS III, L.P.PAUL KLINGENSTEIN

Document Format Files

Seq Description Document Type Size
1 SC 13G d675526dsc13g.htm SC 13G 85867
2 EX-A d675526dex99a.htm EX-99.A 2969
  Complete submission text file 0001193125-14-050940.txt   90408
Mailing Address ONE EMBARCADERO CENTER STE 4000 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER STE 4000 SAN FRANCISCO CA 94111 415-392-7442
Aberdare Ventures III LP (Filed by) CIK: 0001313414 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Subject) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87858 | Film No.: 14605777
SIC: 2834 Pharmaceutical Preparations